Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lecanemab-irmb bulk supplier for pharma manufacturers

Lecanemab-Irmb 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/mL

Reference Brands: Leqembi (USA/EU)

Category: Neurology

Lecanemab-irmb is a humanized monoclonal antibody used for early Alzheimer’s disease. It targets and clears amyloid-beta protofibrils to help slow cognitive and functional decline. The treatment is administered under medical supervision as part of a disease-modifying therapy program for patients with mild cognitive impairment or mild dementia due to Alzheimer’s.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Lecanemab-Irmb — third party manufacturing & bulk supply

Lecanemab-Irmb 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lecanemab-Irmb is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lecanemab-Irmb listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lecanemab-Irmb →
Back to Listing

Frequently Asked Questions

Lecanemab-irmb is used for treating early Alzheimer’s disease, specifically in patients with mild cognitive impairment or mild dementia who have confirmed amyloid-beta buildup in the brain.

It is a humanized IgG1 monoclonal antibody developed to target aggregated forms of amyloid-beta (Aβ) in the brain.

The trade name is Leqembi.

It is developed and marketed by Eisai in partnership with Biogen.

The generic name is Lecanemab-irmb.

The brand name is Leqembi.

It is manufactured by Eisai facilities under global production and quality standards.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.